Prosecution Insights
Last updated: November 20, 2026

Novavax Inc.

Technology area: Biotechnology & Pharmaceuticals

3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Novavax Inc. has 3 pending office actions in Biotechnology & Pharmaceuticals. Those matters involve 3 distinct examiners and 2 distinct art units, so the portfolio spans more than one examination grouping while maintaining a one-examiner-per-action pattern in the available record. The busiest examiner is FOLEY, SHANON A.

FOLEY, SHANON A. is associated with 1 pending matter, while the remaining activity is distributed among other examiners. Counsel may benefit from matter-specific response planning, with art-unit context treated as a meaningful organizing factor. The data supports tracking examiner assignments separately rather than assuming a single prosecution strategy will apply across the portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
3
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (33%)
1
Easy (33%)
1
Unknown (33%)

Rejection Statute Mix

BucketCases
§103 only1 (33%)
§112 only1 (33%)
No statute on record1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FOLEY, SHANON A 1 73.3% +18.2%
ALAM, DANYAL HASSAN 1 66.7% +0.0%
ALLEN, MICHAEL D 1 31.7% +49.0%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18828852 METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE FOLEY, SHANON A —
18645259 SARS-COV-2 VACCINE COMPOSITIONS ALLEN, MICHAEL D —

Top Art Units

Art UnitApps
1671 2
1672 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18828852 METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE FOLEY, SHANON A 1671 Other Non-Final OA — Pending Sep 09, 2024
18723454 ANTI-SARS-CoV-2 SPIKE (S) ANTIBODIES AND THEIR USE IN TREATING COVID-19 ALAM, DANYAL HASSAN 1672 §112 Non-Final OA — Pending Jun 23, 2024
18645259 SARS-COV-2 VACCINE COMPOSITIONS ALLEN, MICHAEL D 1671 §103 Non-Final OA — Pending Apr 24, 2024

Managing Novavax Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Novavax Inc. have?

Novavax Inc. has 3 pending office actions as of November 2026, spread across 2 art units and 3 examiners.

Which USPTO examiner handles the most Novavax Inc. applications?

Shanon A Foley has the most, with 1 of Novavax Inc.'s pending office actions.

What technology area are Novavax Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month